Anaptysbio Inc (ANAB)

Jan 18, 2025

Shareholders May Not Overlook AnaptysBio Insiders Selling US$3.6m In Stock - Simply Wall St

Jan 18, 2025

Jan 17, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 17, 2025

Jan 13, 2025

How AnaptysBio (ANAB) Stock Stands Out in a Strong Industry - Yahoo Finance

Jan 13, 2025

Jan 13, 2025

Barclays PLC Grows Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Jan 13, 2025

Jan 12, 2025

Anaptysbio announces clearance of U.S., India, U.K. CTA for ANB020 - Reuters

Jan 12, 2025

Jan 12, 2025

Big Biotech Fund Loaded Up on Two Stocks - Barron's

Jan 12, 2025

Jan 09, 2025

Are Medical Stocks Lagging United Therapeutics (UTHR) This Year? - Yahoo Finance

Jan 09, 2025

Jan 07, 2025

Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 07, 2025

Jan 07, 2025

AnaptysBio CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 07, 2025

Jan 06, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jan 06, 2025

Jan 06, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jan 06, 2025

Jan 03, 2025

EcoR1 Capital, LLC Increases Stake in AnaptysBio Inc - GuruFocus.com

Jan 03, 2025

Jan 02, 2025

Objective long/short (ANAB) Report - Stock Traders Daily

Jan 02, 2025

Jan 02, 2025

Ecor1 Capital, Llc Acquires 6,646 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock - MarketBeat

Jan 02, 2025

Jan 02, 2025

Ecor1 Capital's Oleg Nodelman acquires $1.1m in AnaptysBio stock By Investing.com - Investing.com South Africa

Jan 02, 2025

Jan 02, 2025

Ecor1 Capital's Oleg Nodelman acquires $1.1m in AnaptysBio stock - Investing.com

Jan 02, 2025

Dec 30, 2024

Geode Capital Management LLC Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 30, 2024

Dec 29, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Barclays PLC - Defense World

Dec 29, 2024

Dec 23, 2024

AnaptysBio stock hits 52-week low at $14.11 amid market challenges - Investing.com

Dec 23, 2024

Dec 23, 2024

How To Trade (ANAB) - Stock Traders Daily

Dec 23, 2024

Dec 22, 2024

State Street Corp Sells 60,670 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 22, 2024

Dec 22, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by State Street Corp - MarketBeat

Dec 22, 2024

Dec 21, 2024

JPMorgan Chase & Co. Lowers AnaptysBio (NASDAQ:ANAB) Price Target to $36.00 - Defense World

Dec 21, 2024

Dec 21, 2024

Franklin Resources Inc. Has $12.31 Million Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Dec 21, 2024

Dec 20, 2024

Truist Financial Has Lowered Expectations for AnaptysBio (NASDAQ:ANAB) Stock Price - Defense World

Dec 20, 2024

Dec 19, 2024

AnaptysBio (NASDAQ:ANAB) Given New $36.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Dec 19, 2024

Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 19, 2024

Dec 19, 2024

Wellington Management Group LLP Grows Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 19, 2024

Dec 19, 2024

AnaptysBio shares target cut, hold rating kept on trial failure By Investing.com - Investing.com Canada

Dec 19, 2024

Dec 18, 2024

AnaptysBio (NASDAQ:ANAB) Shares Gap UpStill a Buy? - MarketBeat

Dec 18, 2024

Dec 18, 2024

Deep Dive Into AnaptysBio Stock: Analyst Perspectives (9 Ratings) - Benzinga

Dec 18, 2024

Dec 18, 2024

AnaptysBio: Doubts About Cash And Upcoming Rheumatoid Arthritis Readout - Seeking Alpha

Dec 18, 2024

Dec 18, 2024

AnaptysBio (NASDAQ:ANAB) Price Target Lowered to $20.00 at Truist Financial - MarketBeat

Dec 18, 2024

Dec 16, 2024

AnaptysBio (NASDAQ:ANAB) Shares Up 9.1%Here's What Happened - MarketBeat

Dec 16, 2024

Dec 16, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Sees Significant Growth in Short Interest - Defense World

Dec 16, 2024

Dec 16, 2024

What is Wedbush’s Estimate for AnaptysBio FY2024 Earnings? - Defense World

Dec 16, 2024

Dec 16, 2024

Short Interest in AnaptysBio, Inc. (NASDAQ:ANAB) Grows By 5.8% - MarketBeat

Dec 16, 2024

Dec 16, 2024

Wedbush Has Negative Forecast for AnaptysBio FY2024 Earnings - MarketBeat

Dec 16, 2024

Dec 16, 2024

Analysts Set Expectations for AnaptysBio FY2024 Earnings - MarketBeat

Dec 16, 2024

Dec 15, 2024

Guggenheim Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $36.00 - Defense World

Dec 15, 2024

Dec 14, 2024

Q1 Earnings Forecast for AnaptysBio Issued By HC Wainwright - Defense World

Dec 14, 2024

Dec 13, 2024

Charles Schwab Investment Management Inc. Has $5.37 Million Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 13, 2024

Dec 13, 2024

AnaptysBio stock hits 52-week low at $14.2 amid market shifts - Investing.com Australia

Dec 13, 2024

Dec 12, 2024

AnaptysBio (NASDAQ:ANAB investor three-year losses grow to 55% as the stock sheds US$261m this past week - Simply Wall St

Dec 12, 2024

Dec 12, 2024

AnaptysBio Stock Under Pressure After Scrapping Eczema Drug Program: Retail Is Devastated - MSN

Dec 12, 2024

Dec 12, 2024

AnaptysBio Stock Down as Eczema Study Fails to Meet Goals - MSN

Dec 12, 2024

Dec 12, 2024

AnaptysBio shares target cut, maintains Buy rating on phase study results - Investing.com UK

Dec 12, 2024

Dec 12, 2024

HC Wainwright & Co. Downgrades AnaptysBio (ANAB) - MSN

Dec 12, 2024

Dec 12, 2024

AnaptysBio’s atopic dermatitis trial of BTLA agonist misses endpoints - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 12, 2024

Dec 12, 2024

AnaptysBio stock hits 52-week low at $14.2 amid market shifts By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

AnaptysBio reports failed Phase 2B trial, maintains cash reserves By Investing.com - Investing.com Canada

Dec 11, 2024